{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:47:55Z","timestamp":1789904875499,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2014A030310505"],"award-info":[{"award-number":["2014A030310505"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012243","name":"Foundation for Distinguished Young Talents in Higher Education of Guangdong","doi-asserted-by":"publisher","award":["C1085229"],"award-info":[{"award-number":["C1085229"]}],"id":[{"id":"10.13039\/501100012243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81402187"],"award-info":[{"award-number":["81402187"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371646"],"award-info":[{"award-number":["81371646"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Free Radical Biology and Medicine"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.freeradbiomed.2017.01.033","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T15:37:21Z","timestamp":1485358641000},"page":"280-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"special_numbering":"C","title":["CQ synergistically sensitizes human colorectal cancer cells to SN-38\/CPT-11 through lysosomal and mitochondrial apoptotic pathway via p53-ROS cross-talk"],"prefix":"10.1016","volume":"104","author":[{"given":"Pinjia","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoyan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinpeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiurong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengzhi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.freeradbiomed.2016.04.016","article-title":"Knockdown of delta-5-desaturase promotes the anti-cancer activity of dihomo-gamma-linolenic acid and enhances the efficacy of chemotherapy in colon cancer cells expressing COX-2","volume":"96","author":"Xu","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib2","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1470-2045(16)30104-8","article-title":"Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial","volume":"17","author":"Goto","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib3","doi-asserted-by":"crossref","first-page":"8736","DOI":"10.18632\/oncotarget.3538","article-title":"PLK1 is a critical determinant of tumor cell sensitivity to CPT11 and its inhibition enhances the drug antitumor efficacy in squamous cell carcinoma models sensitive and resistant to camptothecins","volume":"6","author":"Zuco","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib4","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1200\/JCO.2014.59.7088","article-title":"Epirubicin, cisplatin, and capecitabine versus fluorouracil, leucovorin, and irinotecan for esophagogastric cancer: the original and the rest","volume":"33","author":"Smyth","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib5","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/0006-2952(96)00457-1","article-title":"Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase","volume":"52","author":"Rivory","year":"1996","journal-title":"Biochem. Pharm."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib6","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1200\/JCO.2008.17.6453","article-title":"Urgent need for a new staging system in advanced colorectal cancer","volume":"26","author":"Poston","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib7","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1007\/s10637-014-0070-0","article-title":"Phase II trial of bortezomib alone or in combination with irinotecan in patients with adenocarcinoma of the gastroesophageal junction or stomach","volume":"32","author":"Ocean","year":"2014","journal-title":"Invest. New Drugs"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib8","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1002\/ijc.30127","article-title":"Randomized phase II trial of TEGAFIRI (tegafur\/uracil, oral leucovorin, irinotecan) compared with FOLFIRI (folinic acid, 5-fluorouracil, irinotecan) in patients with unresectable\/recurrent colorectal cancer","volume":"139","author":"Shigeta","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib9","doi-asserted-by":"crossref","first-page":"e1305","DOI":"10.1038\/cddis.2014.265","article-title":"Validation of a chloroquine-induced cell death mechanism for clinical use against malaria","volume":"5","author":"Ch'Ng","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib10","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.4161\/auto.36259","article-title":"How to teach an old dog new tricks: autophagy-independent action of chloroquine on the tumor vasculature","volume":"10","author":"Maes","year":"2014","journal-title":"Autophagy"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib11","doi-asserted-by":"crossref","first-page":"e1860","DOI":"10.1038\/cddis.2015.219","article-title":"alpha-Solanine induces ROS-mediated autophagy through activation of endoplasmic reticulum stress and inhibition of Akt\/mTOR pathway","volume":"6","author":"Hasanain","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib12","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.4161\/auto.22110","article-title":"Aurora kinase A inhibition-induced autophagy triggers drug resistance in breast cancer cells","volume":"8","author":"Zou","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib13","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1126\/science.1099993","article-title":"Autophagy in health and disease: a double-edged sword","volume":"306","author":"Shintani","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib14","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nature06639","article-title":"Autophagy fights disease through cellular self-digestion","volume":"451","author":"Mizushima","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib15","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMc1303158","article-title":"Autophagy in human health and disease","volume":"368","author":"Doria","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1158\/0008-5472.CAN-12-2464","article-title":"Chloroquine in cancer therapy: a double-edged sword of autophagy","volume":"73","author":"Kimura","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib17","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1172\/JCI28833","article-title":"Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma","volume":"117","author":"Amaravadi","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib18","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4161\/auto.8.2.18554","article-title":"Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy","volume":"8","author":"Maycotte","year":"2012","journal-title":"Autophagy"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.ccr.2014.01.021","article-title":"Mutant p53 in cancer: new functions and therapeutic opportunities","volume":"25","author":"Muller","year":"2014","journal-title":"Cancer Cell"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib20","first-page":"647","article-title":"Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression","volume":"11","author":"Kastrinakis","year":"1995","journal-title":"Oncogene"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1073\/pnas.0510146103","article-title":"Analysis of P53 mutations and their expression in 56 colorectal cancer cell lines","volume":"103","author":"Liu","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib22","doi-asserted-by":"crossref","first-page":"26480","DOI":"10.18632\/oncotarget.8419","article-title":"FOXM1 promotes invasion and migration of colorectal cancer cells partially dependent on HSPA5 transactivation","volume":"7","author":"Luo","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib23","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.bbrc.2016.07.063","article-title":"Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors","volume":"478","author":"Zou","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0065-2571(84)90007-4","article-title":"Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors","volume":"22","author":"Chou","year":"1984","journal-title":"Adv. Enzym. Regul."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib25","doi-asserted-by":"crossref","first-page":"e0132880","DOI":"10.1371\/journal.pone.0132880","article-title":"Synergistic effects between mTOR complex 1\/2 and glycolysis inhibitors in non-small-cell lung carcinoma cells","volume":"10","author":"Jiang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib26","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1159\/000374030","article-title":"Synergistic induction of erlotinib-mediated apoptosis by resveratrol in human non-small-cell lung cancer cells by down-regulating survivin and up-regulating PUMA","volume":"35","author":"Nie","year":"2015","journal-title":"Cell Physiol. Biochem."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib27","doi-asserted-by":"crossref","first-page":"e97719","DOI":"10.1371\/journal.pone.0097719","article-title":"Combination of gefitinib and DNA methylation inhibitor decitabine exerts synergistic anti-cancer activity in colon cancer cells","volume":"9","author":"Lou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib28","doi-asserted-by":"crossref","first-page":"15095","DOI":"10.1073\/pnas.2435285100","article-title":"Requirement of p53 targets in chemosensitization of colonic carcinoma to death ligand therapy","volume":"100","author":"Wang","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.freeradbiomed.2008.01.011","article-title":"ROS and p53: a versatile partnership","volume":"44","author":"Liu","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib30","doi-asserted-by":"crossref","first-page":"6434","DOI":"10.1038\/onc.2008.310","article-title":"Lysosomal membrane permeabilization in cell death","volume":"27","author":"Boya","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.2174\/1871520611313050015","article-title":"The role of autophagic cell death and apoptosis in irinotecan-treated p53 null colon cancer cells","volume":"13","author":"Stanislav","year":"2013","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.freeradbiomed.2015.11.018","article-title":"DHA-induced stress response in human colon cancer cells - Focus on oxidative stress and autophagy","volume":"90","author":"Pettersen","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib33","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.freeradbiomed.2015.04.032","article-title":"UCP2 inhibition sensitizes breast cancer cells to therapeutic agents by increasing oxidative stress","volume":"86","author":"Pons","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib34","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00280-004-0904-0","article-title":"Gefitinib (\"Iressa\", ZD1839) inhibits SN38-triggered EGF signals and IL-8 production in gastric cancer cells","volume":"55","author":"Kishida","year":"2005","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2011.09.030","article-title":"Measuring reactive oxygen and nitrogen species with fluorescent probes: challenges and limitations","volume":"52","author":"Kalyanaraman","year":"2012","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib36","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.freeradbiomed.2011.07.015","article-title":"Role of oxidative stress in lysosomal membrane permeabilization and apoptosis induced by gentamicin, an aminoglycoside antibiotic","volume":"51","author":"Denamur","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib37","doi-asserted-by":"crossref","first-page":"e2194","DOI":"10.1038\/cddis.2016.94","article-title":"Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis","volume":"7","author":"Carlisi","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib38","article-title":"Synergistic induction of apoptosis by salinomycin and gefitinib through lysosomal and mitochondrial dependent pathway overcomes gefitinib resistance in colorectal cancer","author":"Zou","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib39","doi-asserted-by":"crossref","first-page":"e0120426","DOI":"10.1371\/journal.pone.0120426","article-title":"Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in non-small cell lung carcinoma cells","volume":"10","author":"Mi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib40","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.freeradbiomed.2011.05.012","article-title":"Selective targeting of breast cancer cells through ROS-mediated mechanisms potentiates the lethality of paclitaxel by a novel diterpene, gelomulide K","volume":"51","author":"Yang","year":"2011","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib41","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd2803","article-title":"Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach","volume":"8","author":"Trachootham","year":"2009","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib42","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.1093\/emboj\/18.23.6845","article-title":"Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation","volume":"18","author":"Bulavin","year":"1999","journal-title":"EMBO J."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib43","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0092-8674(00)80416-X","article-title":"DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2","volume":"91","author":"Shieh","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib44","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1158\/0008-5472.CAN-15-0563","article-title":"p53: protection against tumor growth beyond effects on cell cycle and apoptosis","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib45","doi-asserted-by":"crossref","first-page":"7455","DOI":"10.1073\/pnas.1001006107","article-title":"Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function","volume":"107","author":"Hu","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib46","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/nm1320","article-title":"The antioxidant function of the p53 tumor suppressor","volume":"11","author":"Sablina","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.freeradbiomed.2017.01.033_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/cdd.2012.102","article-title":"The critical role of catalase in prooxidant and antioxidant function of p53","volume":"20","author":"Kang","year":"2013","journal-title":"Cell Death Differ."}],"container-title":["Free Radical Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584917300424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891584917300424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:46:04Z","timestamp":1760204764000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891584917300424"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":47,"alternative-id":["S0891584917300424"],"URL":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.01.033","relation":{},"ISSN":["0891-5849"],"issn-type":[{"value":"0891-5849","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CQ synergistically sensitizes human colorectal cancer cells to SN-38\/CPT-11 through lysosomal and mitochondrial apoptotic pathway via p53-ROS cross-talk","name":"articletitle","label":"Article Title"},{"value":"Free Radical Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}